Micro-Sphere

Micro-Sphere

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Micro-Sphere is a well-established, private Swiss CDMO with a core expertise in spray drying and capsule filling for pharmaceutical applications. The company differentiates itself through specialized technology like electrostatic spray drying for thermolabile compounds and maintains a perfect regulatory track record. It operates as a service provider, supporting clients from R&D through commercial manufacturing, particularly in complex formulations and inhalation drug delivery.

Drug DeliveryMedical Devices

Technology Platform

Specialized pharmaceutical spray drying platform, including conventional and electrostatic (PolarDry) spray dryers for particle engineering, encapsulation, and processing of thermolabile and high-potent compounds. Supported by comprehensive analytical and QbD/DoE development services.

Opportunities

The growing need for solubility enhancement of poorly soluble drugs and the expansion of the inhaled therapeutics market, particularly for biologics, create strong demand for specialized spray drying services.
The company's unique electrostatic drying technology and Swiss regulatory excellence position it to capture high-value projects in these areas.

Risk Factors

Revenue is dependent on a cyclical biopharma outsourcing market and the success of client programs.
Operational risks include maintaining a flawless regulatory compliance record and intense competition from other CDMOs with similar technical capabilities.

Competitive Landscape

Micro-Sphere competes within the niche of advanced spray drying CDMOs against players like Lonza (through its Capsugel division), Hovione, and Pharmaterials. Its differentiation is based on its specific electrostatic drying technology, Swiss location/quality reputation, and focused service offering in spray drying and capsule filling.